OPKO Health Inc.

Proxy Solicitation & Information Statement • Jun 6, 2022

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Filed by the Registrant Filed by a party other than the Registrant

Check the appropriate box:

Preliminary Proxy Statement

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material under 240.14a-12

OPKO Health, Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box)

No fee required

Fee paid previously with preliminary materials.

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

OPKO Health, Inc. Important Notice Regarding the Availability of Proxy Materials

Stockholders Meeting to be held on July 14, 2022

For Stockholders as of May 23, 2022

This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting.

To view the proxy materials, and to obtain directions to attend the meeting, go to: www.proxydocs.com/OPK

To vote your proxy while visiting this site, you will need the 12 digit control number in the box below.

Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet.

For a convenient way to view proxy materials and VOTE go to www.proxydocs.com/OPK

Have the 12 digit control number located in the shaded box above available when you access the website and follow the instructions.

If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's meeting, you must make this request on or before July 01, 2022.

To order paper materials, use one of the following methods.

When requesting via the Internet or telephone you will need the 12 digit control number located in the shaded box above.

If requesting material by Oreall, please send a blank
e-mail with the 12 digit ontrol all, please send a blank
e-mail with the 12 digit ontrol and artisticustion of the only

OPKO Health, Inc.

Meeting Type: Annual Meeting of Stockholders Date: Thursday, July 14, 2022 Time: 10:00 AM, Eastern Time Place: Annual Meeting to be held live via the Internet - please visit www.proxydocs.com/OPK for more details.

You must register to attend the meeting online and/or participate at www.proxydocs.com/OPK

SEE REVERSE FOR FULL AGENDA

OPKO Health, Inc.

Annual Meeting of Stockholders

THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" THE ELECTION OF EACH OF THE NOMINEES FOR DIRECTOR, "FOR" THE SAY ON PAY PROPOSAL, "FOR" THE EQUITY INCENTIVE PLAN SHARE INCREASE, AND "FOR" RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

PROPOSAL

• Election of Directors 1.
  • 1.01 Phillip Frost, M.D.
  • 1.02 Jane H. Hsiao, Ph.D., MBA
  • 1.03 Steven D. Rubin
  • 1.04 Elias A. Zerhouni, M.D.
  • 1.05 Jon R. Cohen, M.D.
  • 1.06 Gary J. Nabel, M.D., Ph.D.
  • 1.07 Alexis Borisv
  • 1.08 Richard M. Krasno, Ph.D.
  • 1.09 Prem A. Lachman, M.D.
  • 1.10 Roger J. Medel, M.D.
  • 1.11 John A. Paganelli
  • 1.12 Richard C. Pfenniger, Jr.
  • 1.13 Alice Lin-Tsing Yu, M.D., Ph.D.
• 1. To approve a non-binding advisory resolution regarding the compensation paid to the Company's named executive officers;
• To amend the OPKO Health, Inc. 2016 Equity Incentive Plan to increase the number of shares issuable thereunder from 30,000,000 to 3. 60,000,000;
• 1. To ratify the appointment of Emst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022;
• 1. To transact such other business as may properly come before the Annual Meeting or any adjournments thereof.